JOHN A. MORAN EYE CENTER RESEARCH: The Science of Hope

Inside 17 labs and centers that comprise more than half of the Moran Eye Center building are our best hopes for finding new ways to preserve and save sight. There, more than 25 faculty researchers are making groundbreaking discoveries by thinking creatively, working collaboratively, and challenging established paradigms.

While faculty members pursue government funding, Moran provides financial support to launch promising research and to sustain it between grants—a commitment made by few other institutions. Critically needed funding comes from donors who enable us to turn discoveries into new treatments as quickly as possible.

Key Research Areas and Accomplishments

Age-Related Macular Degeneration (AMD) is a leading cause of vision loss among adults over 55. Our researchers determined AMD is at least two distinct diseases and are developing treatments for both.

Glaucoma is characterized by high eye pressure that damages the optic nerve. A glaucoma drug developed at Moran is heading toward clinical trials. It is designed to lower pressure and protect cells from damage.

Retinopathy of prematurity is the leading cause of childhood blindness. Our scientists are identifying better ways to determine risk for the disease and to treat it without inhibiting eye development.

Artificial lenses replace the eye’s natural lens for cataract and other patients. A new laser procedure tested at Moran will allow doctors to easily adjust lens power for precise vision after the lens is placed in the eye.

Retinal mapping is being used to study a host of diseases. Our researchers developed the first map showing the circuitry of the retina. Advanced imaging techniques are offering new hope by allowing Moran researchers to detect eye diseases earlier than ever before.

Prosthetics for artificial sight could create a new form of sight as our researchers work to provide independence for people who have lost their vision.